BackBiogen Overview

Biogen Cost of Revenue

Cost of Revenue analysis for BIIB.

Quarterly Cost of Revenue

$661.00M
5.04% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$1.83B
0.98% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)